Defecation disorders: Neuromuscular aspects and treatment

Current Gastroenterology Reports

Volumn 8, Issue 4, 2006, Pages 291-299

  Remes Troche, Jose M ^b   Rao, Satish S C ^a  

^a UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALVIMOPAN; AMITRIPTYLINE; ATROPINE PLUS DIPHENOXYLATE; BISACODYL; CHLORIDE CHANNEL; COLCHICINE; COLESTIPOL; COLESTYRAMINE; DOCUSATE SODIUM; ENDOTHELIN B RECEPTOR; GUANINE NUCLEOTIDE BINDING PROTEIN; ISPAGULA; LACTULOSE; LOPERAMIDE; LUBIPROSTONE; MACROGOL 4000; METHYLCELLULOSE; MISOPROSTOL; MOSAPRIDE CITRATE; NEUROTROPHIN 3; PHENYLEPHRINE; PLACEBO; POLYCARBOPHIL CALCIUM; PROGESTERONE RECEPTOR; RENZAPRIDE; SENNA EXTRACT; SEROTONIN 4 RECEPTOR; TEGASEROD; UNINDEXED DRUG; VALPROIC ACID;

ABDOMINAL PAIN; AGING; BLOATING; CHRONIC DISEASE; CLINICAL TRIAL; COLON RESECTION; CONSTIPATION; DIARRHEA; DISEASE CLASSIFICATION; DRUG DOSE REGIMEN; DRUG MECHANISM; ECONOMIC ASPECT; EXERCISE; FECES INCONTINENCE; FEEDBACK SYSTEM; FLATULENCE; HEADACHE; HIRSCHSPRUNG DISEASE; HUMAN; HYDRATION; LIFESTYLE; LOOSE FECES; NAUSEA; NERVE STIMULATION; NEUROMUSCULAR DISEASE; NEUROMUSCULAR FUNCTION; NURSING HOME PATIENT; PATHOPHYSIOLOGY; PREVALENCE; QUALITY OF LIFE; RADIOFREQUENCY; RECTUM; REVIEW; RHINOPHARYNGITIS; SEX DIFFERENCE; SOCIOECONOMICS; STOMACH DISTENSION;

BIOFEEDBACK (PSYCHOLOGY); CONSTIPATION; DEFECATION; DIGESTIVE SYSTEM SURGICAL PROCEDURES; FECAL INCONTINENCE; GASTROINTESTINAL AGENTS; HUMANS; TREATMENT OUTCOME;

EID: 33746873620     PISSN: 15228037     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11894-006-0049-x     Document Type: Review

References (66)

1. Rao SS: Constipation: evaluation and treatment. Gastroenterol Clin North Am 2003, 32:659-683.
2. Hobson AR, Aziz Q. Brain imaging and functional gastrointestinal disorders: has it helped our understanding? Gut 2004, 53:1198-1206.
3. Mayer EA, Berman S, Suyenobu B, et al.: Differences in brain responses to visceral pain between patients with irritable bowel syndrome and ulcerative colitis. Pain 2005, 115:398-409.
4. Hobday DI, Aziz Q, Thacker N, et al.: A study of the cortical processing of ano-rectal sensations using functional MRI. Brain 2001, 124:361-368.
5. Lawal A, Kern M, Sanjeevi A, et al.: Cingulate cortex: a closer look at its gut-related functional topography. Am J Physiol Gastrointest Liver Physiol 2005, 289: G722-G730.
6. Derbyshire SW: A systematic review of neuroimaging data during visceral stimulation. Am J Gastroenterol 2003, 98:12-20.
7. Lynn PA, Olsson C, Zagorodnyuk V, et al.: Rectal intraganglionic laminar endings are transduction sites of extrinsic mechanoreceptors in the guinea pig rectum. Gastroenterology 2003, 125:786-794.
8. Wood JD: Enteric neuroimmunophysiology and pathophysiology. Gastroenterology 2004, 127:635-657.
9. Rao SC, Miller M, DeOcampo S: Anorectal sensori-motor reflex in humans [abstract]. Gastroenterology 2005, 128(Suppl 2):A38 (250).
10. Remes-Troche JM, DeOcampo S, Miller MJ, et al.: Investigation of the sensori-motor, rectoanal inhibitory and contractile reflexes in rectal hyposensitivity [abstract]. Gastroenterology 2006, 130(Suppl 2):A115 (787).
11. Lembo A, Camilleri M: Chronic constipation. N Engl J Med 2003, 349:1360-1368.
12. Rao SS, Sadeghi P, Beaty J, Kavlock R: Ambulatory 24-hour colonic manometry in slow-transit constipation. Am J Gastroenterol 2004, 99:2405-2416.
13. Rao SSC, Welcher KD, Leistikow JS: Obstructive defecation: a failure of rectoanal coordination. Am J Gastroenterol 1998, 93:1042-1050.
14. Bassoti G, de Roberto G, Castellani D, et al.: Normal aspects of colorectal motility and abnormalities in slow transit constipation World J Gastroenterol 2005, 11:2691-2696.
15. Rao SS, Sadeghi P, Batterson K, Beaty J: Altered periodic rectal motor activity: a mechanism for slow transit constipation. Neurogastroenterol Motil 2001, 13:591-598.
16. Herve S, Savoye G, Behbahani A, et al.: Results of 24-h manometric recording of colonic motor activity with endoluminal instillation of bisacodyl in patients with severe chronic slow transit constipation. . Neurogastroenterol Motil 2004, 16:397-402.
17. Lee JI, Park H, Kamm MA, Talbot IC: Decreased density of interstitial cells of Cajal and neuronal cells in patients with slow transit constipation and acquired megacolon. J Gastroenterol Hepatol 2005, 20:1292-1298.
18. Bassotti G, Villanacci V, Maurer CA, et al.: The role of glial cells and apoptosis of the enteric neurons in the neuropathology of intractable slow transit constipation. Gut 2006, 55:41-46.
19. Puri P, Shinkai T: Pathogenesis of Hirschsprung's disease and its variants: recent progress. Semin Pediatr Surg 2004,13:18-24.
20. Xiao ZL, Pricolo V, Biancani P, Behar J: Role of progesterone signaling in the regulation of G-protein levels in female chronic constipation. Gastroenterology 2005, 128:667-675.
21. Rao SS, Tuteja AK, Vellema T, et al.: Dyssynergic defecation: demographics, symptoms, stool patterns, and quality of life. J Clin Gastroenterol. 2004, 38:680-685.
22. Bharucha AE, Fletcher JG, Seide B, et al.: Phenotypic variation in functional disorders of defecation. Gastroenterology 2005, 128:1199-1210.
23. Crowell MD, Harris L, Jones MP, Chang L: New insights into the pathophysiology of irritable bowel syndrome: implications for future treatments. Curr Gastroenterol Rep 2005, 7:272-279.
24. Muller-Lissner SA, Kamm MA, Scarpignato C, Wald A:. Myths and misconceptions about chronic constipation. Am J Gastroenterol 2005, 100: 32-242.
25. Ramkumar D, Rao SSC. Efficacy and safety of traditional medical therapies for chronic constipation: Systematic review. Am J Gastroenterol 2005, 100: 936-971.
26. Brandt LJ, Prather CM, Quigley EMM, et al.: Systematic review on the management of chronic constipation in North America. Am J Gastroenterol 2005, 100 (Suppl 1), S5-SS22.
27. Corazziari E, Badiali D, Bazzocchi G, et al.: Long term efficacy, safety and tolerability of low daily doses of isosmotic polyethylene glycol electrolyte balanced solution (PMF-100) in the treatment of functional chronic constipation. Gut 2000, 46:522-526.
28. Fritz E, Hammer HF, Lipp RW, et al.: Effects of lactulose and polyethylene glycol on colonic transit. Aliment Pharmacol Ther 2005, 21:259-268.
29. Johanson JF, Wald A, Tougas G, et al.: Effect of tegaserod in chronic constipation: a randomized, double-blind, controlled trial. Clin Gastroenterol Hepatol 2004, 2:796-805.
30. Shetzline M, Dolker M, Bottoli I, Cohard-Radice M: Patients with chronic constipation who respond to tegaserod after 4 weeks maintain symptom improvement for over 13 months. Am J Gastroenterol 2005, 100(Suppl 7):S339.
31. Liu Z, Sakakibara R, Odaka T, et al.: Mosapride citrate, a novel 5-HT4 agonist and partial 5-HT3 antagonist, ameliorates constipation in Parkinsonian patients. Mov Disord 2005, 20:680-686.
32. Camilleri M, McKinzie S, Fox J, et al.: Effect of renzapride on transit in constipation-predominant irritable bowel syndrome. Clin Gastroenterol Hepatol 2004, 2:895-904.
33. Verne GN, Davis RH, Robinson ME, et al.: Treatment of chronic constipation with colchicine: randomized, double-blind, placebo- controlled, crossover trial. Am J Gastroenterol 2003, 98:1112-1116.
34. Johanson JF, Gargano MA, Holland PC, et al.: Phase III efficacy and safety of RU-0211, a novel chloride channel activator, for the treatment of constipation. Gastroenterology 2003, 124(Suppl 1):A48.
35. Parkman HP, Rao SS, Reynolds JC, et al.: Neurotrophin-3 improves functional constipation. Am J Gastroenterol 2003, 98:1338-1347.
36. Gonenne J, Camilleri M, Ferber I, et al.: Effect of alvimopan and codeine on gastrointestinal transit: a randomized controlled study. Clin Gastroenterol Hepatol 2005, 3:784-791.
37. Rao SS, Kinkade KJ, Schulze KS, et al.: Biofeedback therapy for dyssynergy constipation-randomized controlled trial. Gastroenterology 2005, 128:A269.
38. Heymen S, Scarlett Y, Jones K, et al.: Randomized controlled trial shows biofeedback to be superior to alternative treatments for patients with pelvic floor dyssynergya-type constipation. Gastroenterology 2005, 128:A266.
39. Chiarioni G, Whitehead WE, Pezza V, et al.: Biofeedback is superior to laxatives for normal transit constipation due to pelvic floor dyssynergya. Gastroenterology 2006, 130:657-664.
40. Rao SSC: Pathophysiology of adult fecal incontinence. Gastroenterology 2004, 126 (Suppl 1): S14-S22.
41. Bharucha AE, Zinsmeister AR, Locke GR, et al.: Prevalence and burden of fecal incontinence: a population-based study in women. Gastroenterology 2005, 129:42-49.
42. Rao SS, American College of Gastroenterology Practice Parameters Committee. Diagnosis and management of fecal incontinence. American College of Gastroenterology Practice Parameters Committee. Am J Gastroenterol 2004, 99:1585-1604.
43. Fornell EU, Matthiessen L, Sjodahl R, Berg G. Obstetric anal injury ten years after: subjective and objective long term effects. BJOG 2005, 112:312-316.
44. Damon H, Bretones S, Henry L, et al.: Long-term consequences of first vaginal delivery-induced anal sphincter defect. Dis Colon Rectum 2005, 48:1772-1776.
45. Johannsson HO, Graf W, Pahlman L: Long-term results of haemorrhoidectomy. Eur J Surg 2002, 168:485-489.
46. Bharucha AE, Fletcher JG, Harper CM, et al.: Relationship between symptoms and disordered continence mechanisms in women with idiopathic faecal incontinence. Gut 2005, 54:546-555.
47. Fernandez-Fraga X, Azpiroz F, Malagelada JR: Significance of pelvic floor muscles in anal incontinence. Gastroenterology 2002,123:1441-1450.
48. Chan CL, Lunniss PJ, Wang D, et al.: Rectal sensorimotor dysfunction in patients with urge faecal incontinence: evidence from prolonged manometric studies. Gut 2005, 54:1263-1272.
49. Chan CL, Scott SM, Williams NS, Lunniss PJ: Rectal hypersensitivity worsens stool frequency, urgency, and lifestyle in patients with urge fecal incontinence. Dis Colon Rectum 2005, 48:134-140.
50. Rao SS, Ozturk R, Stessman M: Investigation of the pathophysiology of fecal seepage. Am J Gastroenterol 2004, 99:2204-2209.
51. Andrews CN, Bharucha A: The etiology, assessment, and treatment of fecal incontinence. Nat Clin Pract Gastroenterol Hepatol 2005, 2:516-525.
52. Norton C, Chelvanayagam S, Wilson-Barnett J, et al.: Randomized controlled trial of biofeedback for fecal incontinence. Gastroenterology 2003, 125:1320-1329.
53. Ozturk R, Niazi S, Stessman M, Rao SS: Long-term outcome and objective changes of anorectal function after biofeedback therapy for faecal incontinence. Aliment Pharmacol Ther 2004, 20:667-674.
54. Byrne CM, Solomon MJ, Rex J, et al.: Telephone vs. face-to-face biofeedback for fecal incontinence: comparison for two techniques in 239 patients. Dis Colon Rectum 2005, 48:2281-2288.
55. Madoff RD: Surgical treatment options for fecal incontinence. Gastroenterology 2004, 126 (Suppl 1):S48-S54.
56. Zorcolo L, Covotta L, Bartolo DC: Outcome of anterior sphincter repair for obstetric injury: comparison of early and late results. Dis Colon Rectum 2005, 48:524-531.
57. Thornton MJ, Kennedy ML, Lubowski DZ, King DW: Long-term follow-up of dynamic graciloplasty for faecal incontinence. Colorectal Disease 2004, 6:470-476.
58. Mundy L, Merlin TL, Maddern GJ, Hiller JE: Systematic review of safety and effectiveness of an artificial bowel sphincter for faecal incontinence. Br J Surg 2004, 91:665-672.
59. Norton C, Burch J, Kamm MA: Patient's views of a colostomy for fecal incontinence. Dis Colon Rectum 2005, 48:1062-1069.
60. Deutekom M, Dobben A: Plugs for containing faecal incontinence. Cochrane Database Syst Rev 2005, 3:CD005086.
61. Vaizey CJ, Kamm MA: Injectable bulking agents for treating faecal incontinence. Br J Surg 2005, 92:521-527
62. Norton C, Gibbs A, Kamm MA. Randomized, controlled trial of anal electrical stimulation for fecal incontinence. Dis Colon Rectum 2006, 49:190-196
63. Leroi AM, Parc Y, Lehur PA et al.: Sacral nerve stimulation for fecal incontinence. Results of a multicenter double-blind crossover study. Ann Surg 2005, 242:662-669.
64. Takahashi T, Garcia-Osogobio S, Valdovinos MA, et al.: Extended two-year results of radio-frequency energy delivery for the treatment of fecal incontinence (the Secca procedure). Dis Colon Rectum 2003, 46:711-775.
65. Efron JE, Corman ML, Fleshman J, et al.: Safety and effectiveness of temperature-controlled radio-frequency energy delivery to the anal canal (Secca(R) procedure) for the treatment of fecal incontinence. Dis Colon Rectum 2003, 46:1606-1616.
66. Garcia-Olmo D, Garcia-Arranz M, Garcia LG, et al.: Autologous stem cell transplantation for treatment of rectovaginal fistula in perianal Crohn's disease: a new cell-based therapy. Int J Colorectal Dis 2003,18:451-454.